Danaher Total Assets increased by 0.1% to $83.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $79.12B to $83.54B. Over 5 years (FY 2020 to FY 2025), Total Assets shows relatively stable performance with a 1.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in total assets generally signals company expansion, though it must be evaluated against the growth in liabilities and equity.
This is the sum of all current and non-current assets owned by the company, representing the total economic resources co...
Total assets are used as a primary benchmark for comparing the scale of operations across industry peers.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.03B | $82.50B | $83.18B | $83.39B | $81.81B | $81.03B | $84.35B | $85.04B | $84.90B | $87.73B | $84.49B | $83.40B | $78.56B | $80.62B | $77.54B | $79.12B | $81.62B | $79.90B | $83.46B | $83.54B |
| QoQ Change | — | +5.7% | +0.8% | +0.3% | -1.9% | -0.9% | +4.1% | +0.8% | -0.2% | +3.3% | -3.7% | -1.3% | -5.8% | +2.6% | -3.8% | +2.0% | +3.2% | -2.1% | +4.5% | +0.1% |
| YoY Change | — | — | — | — | +4.8% | -1.8% | +1.4% | +2.0% | +3.8% | +8.3% | +0.2% | -1.9% | -7.5% | -8.1% | -8.2% | -5.1% | +3.9% | -0.9% | +7.6% | +5.6% |
| Segment | Q4 '22 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|
| Biotechnology | $37.54B | $36.12B | $37.56B | $37.30B | $37.34B | $36.70B |
| Life Sciences | — | — | — | — | $23.11B | $22.87B |
| Diagnostics | — | — | — | — | $14.75B | $14.66B |
| Total | $84.35B | $79.12B | $81.62B | $79.90B | $83.46B | $83.54B |